rs147458082

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001003841.3(SLC6A19):​c.41G>A​(p.Arg14Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00126 in 1,610,690 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R14W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0018 ( 7 hom., cov: 34)
Exomes 𝑓: 0.0012 ( 25 hom. )

Consequence

SLC6A19
NM_001003841.3 missense

Scores

1
7
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 6.42

Publications

7 publications found
Variant links:
Genes affected
SLC6A19 (HGNC:27960): (solute carrier family 6 member 19) This gene encodes a system B(0) transmembrane protein that actively transports most neutral amino acids across the apical membrane of epithelial cells. Mutations in this gene may result in Hartnup disorder, an inherited disease with symptoms such as pellagra, cerebellar ataxia, and psychosis. The expression and function of B0AT1 (SLC6A19) in intestinal cells depends on the presence of the accessory protein angiotensin-converting enzyme 2 (ACE2) which, among other functions, acts as a chaperone for membrane trafficking of B0AT1. The ACE2 is also the cellular receptor for severe acute respiratory syndrome-coronavirus (SARS-CoV) and for SARS-CoV-2 that is causing the coronavirus 2019 (COVID-19) pandemic [provided by RefSeq, Jul 2020]
SLC6A19 Gene-Disease associations (from GenCC):
  • Hartnup disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0055764914).
BP6
Variant 5-1201691-G-A is Benign according to our data. Variant chr5-1201691-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445301.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00181 (275/152314) while in subpopulation EAS AF = 0.039 (202/5180). AF 95% confidence interval is 0.0346. There are 7 homozygotes in GnomAd4. There are 160 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A19NM_001003841.3 linkc.41G>A p.Arg14Gln missense_variant Exon 1 of 12 ENST00000304460.11 NP_001003841.1 Q695T7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A19ENST00000304460.11 linkc.41G>A p.Arg14Gln missense_variant Exon 1 of 12 1 NM_001003841.3 ENSP00000305302.10 Q695T7
SLC6A19ENST00000515652.5 linkn.41G>A non_coding_transcript_exon_variant Exon 1 of 11 2 ENSP00000425701.1 E9PD72

Frequencies

GnomAD3 genomes
AF:
0.00182
AC:
277
AN:
152196
Hom.:
7
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000845
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0387
Gnomad SAS
AF:
0.00704
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00358
AC:
880
AN:
245624
AF XY:
0.00334
show subpopulations
Gnomad AFR exome
AF:
0.00101
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0374
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000629
Gnomad OTH exome
AF:
0.00233
GnomAD4 exome
AF:
0.00121
AC:
1761
AN:
1458376
Hom.:
25
Cov.:
31
AF XY:
0.00130
AC XY:
942
AN XY:
725654
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33460
American (AMR)
AF:
0.000157
AC:
7
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26102
East Asian (EAS)
AF:
0.0281
AC:
1113
AN:
39666
South Asian (SAS)
AF:
0.00476
AC:
410
AN:
86196
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50524
Middle Eastern (MID)
AF:
0.00248
AC:
14
AN:
5654
European-Non Finnish (NFE)
AF:
0.0000819
AC:
91
AN:
1111780
Other (OTH)
AF:
0.00192
AC:
116
AN:
60310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
128
255
383
510
638
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00181
AC:
275
AN:
152314
Hom.:
7
Cov.:
34
AF XY:
0.00215
AC XY:
160
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.000842
AC:
35
AN:
41564
American (AMR)
AF:
0.0000653
AC:
1
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0390
AC:
202
AN:
5180
South Asian (SAS)
AF:
0.00684
AC:
33
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68018
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00130
Hom.:
5
Bravo
AF:
0.00208
ESP6500AA
AF:
0.000911
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00371
AC:
449
Asia WGS
AF:
0.0280
AC:
96
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 08, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.11
CADD
Uncertain
26
DANN
Uncertain
0.99
DEOGEN2
Benign
0.11
T
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.96
D
MetaRNN
Benign
0.0056
T
MetaSVM
Benign
-0.62
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
6.4
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-0.51
N
REVEL
Uncertain
0.36
Sift
Benign
0.38
T
Sift4G
Benign
0.43
T
Polyphen
1.0
D
Vest4
0.42
MVP
0.84
MPC
0.80
ClinPred
0.031
T
GERP RS
4.0
PromoterAI
-0.018
Neutral
Varity_R
0.22
gMVP
0.65
Mutation Taster
=71/29
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147458082; hg19: chr5-1201806; COSMIC: COSV58675442; API